1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration

The objective of this study was to establish in vivo 1H‐magnetic resonance (MR) spectroscopic appearances of cervical cancer using an endovaginal receiver coil and corroborate findings with magic angle spinning (MAS) MR spectroscopy of tissue samples. Fifty‐three women (14 controls and 39 with cervical cancer) underwent endovaginal coil MR imaging at 1.5 T with T1‐ and T2‐weighted scans sagittal and transverse to the cervix. Localized 1H MR spectra (PRESS technique, TR 1600 ms, TE 135 ms) were accumulated in all controls and 29 cancer patients whose tumour filled > 50% of a single 3.4 cm3 voxel. Peaks from triglyceride‐CH2 and ‐CH3 were defined as present and in‐phase (with the choline resonance), present but out‐of‐phase, or not present. Peak areas of choline‐containing compounds were standardized to the area of unsuppressed tissue water resonance. Comparisons in observed resonances between groups were made using Fisher's exact test (qualitative data) and a t‐test (quantitative data). Biopsies from these women analysed using MAS‐MR spectroscopy and normalized to the intensity of an external standard of silicone rubber were similarly compared. Adequate water suppression permitted spectral analysis in 11 controls and 27 cancer patients. In‐phase triglyceride‐CH2 resonances (1.3 ppm) were observed in 74% of tumours but in no control women (p < 0.001). No differences were observed in the presence of a 2 ppm resonance, choline‐containing compounds or creatine in cancer compared with control women. However, ex vivo analysis showed significant differences not only in CH2, but also in CH3, a 2 ppm resonance, choline‐containing compounds and creatine between tissues from control women and cancer tissue (p < 0.001, = 0.001, = 0.036, < 0.001 and = 0.004 respectively). On in vivo 1H‐MR spectroscopy, the presence of positive triglyceride‐CH2 resonances can be used to detect and confirm the presence of cervical cancer. However, technical improvements are required before routine clinical use. Copyright © 2004 John Wiley & Sons, Ltd.

[1]  I Barba,et al.  The relationship between nuclear magnetic resonance-visible lipids, lipid droplets, and cell proliferation in cultured C6 cells. , 1999, Cancer research.

[2]  Ian C. P. Smith,et al.  1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue , 1994, NMR in biomedicine.

[3]  P. Carroll,et al.  Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.

[4]  S F Keevil,et al.  The performance of volume selection sequences for in vivo NMR spectroscopy: implications for quantitative MRS. , 2001, Magnetic resonance imaging.

[5]  J. Kurhanewicz,et al.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer , 2002, Journal of magnetic resonance imaging : JMRI.

[6]  J. Frahm,et al.  Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. , 1989, Radiology.

[7]  C. Mountford,et al.  Proton MR and human cervical neoplasia: ex vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in situ and other preinvasive lesions. , 1993, Radiology.

[8]  G. Sutherland,et al.  Mobile lipids and metabolic heterogeneity of brain tumours as detectable by Ex Vivo 1H MR spectroscopy , 1994, NMR in biomedicine.

[9]  J. Mohler,et al.  In vitro high resolution 1h‐spectroscopy of the human prostate: Benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma , 1993, Magnetic resonance in medicine.

[10]  D. Cory,et al.  Classification of human liposarcoma and lipoma using ex vivo proton NMR spectroscopy , 1999, Magnetic resonance in medicine.

[11]  J. Nicholson,et al.  High‐resolution 1H NMR and magic angle spinning NMR spectroscopic investigation of the biochemical effects of 2‐bromoethanamine in intact renal and hepatic tissue , 2001, Magnetic resonance in medicine.

[12]  J. H. Lee,et al.  Localized in vivo 1H nuclear MR spectroscopy for evaluation of human uterine cervical carcinoma. , 1998, AJR. American journal of roentgenology.

[13]  J. Griffin,et al.  The biochemical profile of rat testicular tissue as measured by magic angle spinning 1H NMR spectroscopy , 2000, FEBS letters.

[14]  D. Louis Collins,et al.  Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.

[15]  D. Cory,et al.  Gradient, high‐resolution, magic‐angle spinning nuclear magnetic resonance spectroscopy of human adipocyte tissue , 1997, Magnetic resonance in medicine.

[16]  James R. Allen,et al.  In Vivo Proton (H1) Magnetic Resonance Spectroscopy for Cervical Carcinoma , 2001, American journal of clinical oncology.

[17]  K. Brindle,et al.  The appearance of neutral lipid signals in the 1H NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplets , 1993, Magnetic resonance in medicine.

[18]  F. Blankenberg,et al.  Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. , 1997, Blood.

[19]  P. Matarrese,et al.  1H‐MRS lipid signal modulation and morphological and ultrastructural changes related to tumor cell proliferation , 1999, Magnetic resonance in medicine.

[20]  N. deSouza,et al.  High-resolution MR imaging of stage I cervical neoplasia with a dedicated transvaginal coil: MR features and correlation of imaging and pathologic findings. , 1996, AJR. American journal of roentgenology.

[21]  D J Collins,et al.  Quantification of signal selection efficiency, extra volume suppression and contamination for ISIS, STEAM and PRESS localized 1H NMR spectroscopy using an EEC localization test object , 1995, Physics in medicine and biology.

[22]  Roland G Henry,et al.  Characterization of untreated gliomas by magnetic resonance spectroscopic imaging. , 2002, Neuroimaging clinics of North America.

[23]  Barbara L. Smith,et al.  Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy. , 1998, Journal of magnetic resonance.

[24]  I. Gribbestad,et al.  Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy , 1999, Journal of magnetic resonance imaging : JMRI.

[25]  Susan M. Chang,et al.  Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors. , 2001, Magnetic resonance imaging.

[26]  R. Sauter,et al.  Intratumoral lipids in 1H MRS in vivo in brain tumors: experience of the Siemens cooperative clinical trial. , 1996, Anticancer research.

[27]  J. Kurhanewicz,et al.  Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical study , 1993, Magnetic resonance in medicine.

[28]  N M deSouza,et al.  Value of magnetic resonance imaging with an endovaginal receiver coil in the pre‐operative assessment of Stage I and IIa cervical neoplasia , 1998, British journal of obstetrics and gynaecology.